Skip to content

Clinical trials

Hepatitis trials in New Zealand

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatitis Country / region: New Zealand Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20101
20123
20133
20151
20181
20202
20212
20222
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15
Active, not recruiting2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Gilead Sciences8
Vir Biotechnology, Inc.6
AusperBio Therapeutics Inc.1
Brii Biosciences Limited1
GlaxoSmithKline1
Novartis Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatitis18
Hepatitis B9
Hepatitis B, Chronic9
Hepatitis C2
Hepatitis D2
Hepatitis D, Chronic2
Hepatitis, Chronic2
Liver Diseases2
Blood-Borne Infections1
Bronchiolitis Obliterans Syndrome1

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.